Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Annals of Hematology|September 16, 2020
Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donorsStefani Parmentier, Michael Kramer, Swetlana Weller, et al.
Cancer Chemotherapy and Pharmacology|September 5, 2003
Increased myelotoxicity of idarubicin: is there a pharmacological basis? Results of a pharmacokinetic and an in vitro cytotoxicity studyFrank Kroschinsky, Eberhard Schleyer, Ulf Renner, et al.
Blood|December 7, 2007
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patientsHannes Wandt, Ulrike Schäkel, Frank Kroschinsky, et al.
Blood|May 10, 2013
The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AMLNona Shayegi, Michael Kramer, Martin Bornhäuser, et al.
Annals of Hematology|July 5, 2020
Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemiaDesiree Kunadt, Christian Dransfeld, Claudia Dill, et al.
Haematologica|August 6, 2002
Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 yearsMarkus Schaich, Thomas Illmer, Walter Aulitzky, et al.
Cancer Research|September 5, 2002
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patientsThomas Illmer, Ulrich S Schuler, Christian Thiede, et al.
Transfusion|August 29, 2006
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myelomaFrank Kroschinsky, Kristina Hölig, Uwe Platzbecker, et al.
Haematologica|January 29, 2008
Cup-like acute myeloid leukemia: new disease or artificial phenomenon?Frank P Kroschinsky, Ulrike Schäkel, Rainer Fischer, et al.
Haematologica|December 20, 2011
Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donorsStefani Parmentier, Johannes Schetelig, Kerstin Lorenz, et al.
Pageof 9